ADP-Ribosylation factor 6 regulates tumorigenic and invasive properties in vivo

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2201-2209

  Muralidharan Chari, Vandhana ^a   Hoover, Holly ^a   Clancy, James ^a   Schweitzer, Jill ^a   Suckow, Mark A ^a   Schroeder, Valerie ^a   Castellino, Francis J ^a   Schorey, Jeffrey S ^a   D'Souza Schorey, Crislyn ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; MITOGEN ACTIVATED PROTEIN KINASE; RAC1 PROTEIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADP-RIBOSYLATION FACTOR 6; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PHOSPHOLIPASE D;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; LUNG METASTASIS; MALE; MELANOMA; MICROSCOPY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL GROWTH; ENZYME ACTIVATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MICE; PHOSPHOLIPASE D;

EID: 65549106079     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1301     Document Type: Article

References (31)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Chen WT, Wang JY. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N y Acad Sci 1999;878:361-71.
3. Monsky WL, Lin CY, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994;54:5702-10.
4. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane, J Biol Chem 2003;278:41573-6.
5. D'Souza-Sehorey C, Chavrier P. ART proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006;7:347-58.
6. Tague SE, Muralidharan V, D'Souza-Schorey C. ADP- ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc Natl Acad Sci U S A 2004;101:9671-6.
7. Hashimoto S, Onodera Y, Hashimoto A, et al. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A 2004;101:6647-52.
8. Li M, Ng SS, Wang J, et al. EVA6A enhances glioma cell invasion through ADP ribosylation factor 6/ extracellular signal-regulated kinase signaling. Cancer Res 2006;66:1583-90.
9. Zeniou-Meyer M, Zabari N, Ashery U, et al. Phospho- lipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage, J Biol Chem 2007;282:21746-57.
10. Boshans RL, Szanto S, van Aelst L, et al. ADP-ribosylation factor 6 regulates actin cytoskeleton remodeling in coordination with Racl and RhoA. Mol Cell Biol 2000;20:3685-94.
11. Hoover H, Muralidharan-Chari V, Tague S, et al. Investigating the role of ADP-ribosylation factor 6 in tumor cell invasion and extracellular signal-regulated kinase activation. Methods Enzymol 2005;404:134-47.
12. Cirri P, Taddei ML, Chiarugi P, et al. Insulin inhibits platelet-derived growth factor-induced cell proliferation. Mol Biol Cell 2005;16:73-83.
13. Whiteland JL, Nicholls sm, Shimeld C, et al. Irnrnunohistochemical Detection of T-cell subsets and other leukocytes in paraffin-embedded Rat and Mouse tissues with monoclonal antibodies, J Histochem Cytochem 1995;43:313-20.
14. Webb CP, Van Aelst L, Wigler MH, et al. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A 1998;95:8773-8.
15. Schweitzer JK, D'Souza-Schorey C. Localization and activation of the ARF6 GTPase during cleavage furrow ingression and cytokinesis, J Biol Chem 2002;277:27210-6.
16. Arvanitis C, Felsher DW. Conditionally MYC: insights from novel transgenic models. Cancer Lett 2005;226:95-9.
17. Weed SA, Du Y, Parsons JT. Translocation of cortactin to the cell periphery is mediated by the small GTPase Rack J Cell Sci 1998;111:2433-43.
18. Kjonniksen I, Storeng R, Pihl A, et al. A human tumor lung metastasis model in athymic nude rate. Cancer Res 1989;49:5148-52.
19. Yang M, Jiang P, An Z, et al. Genetically fluorescent melanoma bone and organ metastasis models. Clin Cancer Res 1999;5:3549-59.
20. Kodrik V, Gomes E, Hui L, et al. Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells. FEBS Lett 2006;580:5647-52.
21. Zheng Y, Rodrik V, Toschi A, et al. Phospholipase D couples survival and migration signals in stress response of human cancer cells, j Biol Chem 2006; 281:15862-8.
22. Andresen BT, Rizzo MA, Shome K, et al. The role of phosphatidic acid in the regulation of the Ras/MEK/ Erk signaling cascade. fees Lett 2002;531:65-8.
23. Hong JH, Oh SO, Lee M, et al. Enhancement of lysophosphatidic acid-induced erk phosphorylation by phospholipase Dl via the formation of phospha- tidic acid. Biochem Biophys Res Commun 2001;281: 1337-42.
24. Vial E, Sahai E, Marshall Cj. ERK-MAPK signaling coordinately regulates activity of Racl and RhoA for tumor cell motility. Cancer Cell 2003;4:67-79.
25. Osenkowski P, Toth M, Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (mt1-mmp). j Cell Physiol 2004;200: 2-10.
26. Dyer N, Kebollo E, Dominguez P, et al. Spermatocyte cytokinesis requires rapid membrane addition mediated by ARF6 on central spindle recycling endosomes. Development 2007;134:4437-47.
27. Schweitzer JK, D'Souza-Schorey C. A requirement for ARF6 during the completion of cytokinesis. Exp Cell Res 2005;311:74-83.
28. Fielding AB, Schonteich E, Matheson J, et al. Rabll-3 and 1-TP4 interact with Arft and the exocyst to control membrane traffic in cytokinesis. EMBO J 2005;24:3389-99.
29. Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol 1998;16: 2686-92.
30. Kemp CJ, Don eho wer LA, Bradley A, et al. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993;74:813-22.
31. Malliri A, van der Kammen RA, Clark K, at al. Mice deficient in the Rac activator Tiaml are resistant to Ras-induced skin tumours. Nature 2002;417:867-71.